Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery

Strahlentherapie und Onkologie

Volumn 176, Issue 2, 2000, Pages 73-80

  Wagner, Wolfgang ^a   Hermann, Robert ^b   Hartlapp, Joachim ^b   Esser, Elmar ^b   Christoph, Bernhard ^b   Müller, Michael Karl ^b   Krech, Rainer ^b   Koch, Olaf ^b  

^a Paracelsus Klinik Osnabruck   (Germany)

^b NONE

Author keywords

Hemoglobin concentrations; Locally advanced head and neck cancer; Neoadjuvant combined radio chemotherapy; Prognostic factors

Indexed keywords

CISPLATIN; HEMOGLOBIN; IFOSFAMIDE; MESNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; NAUSEA; NECK DISSECTION; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME; VOMITING;

EID: 0033954883     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002331     Document Type: Article

References (37)

1. Adelstein DJ. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer. Curr Opin Oncol 1998; 10:213-8.
2. Adelstein DJ, Saxton JP, Lavertu P, et al. A phase HI randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997;19:567-75.
3. Becker A, Hansgen G, Richter C, Dunst J. Oxygenation status of squamous cell carcinoma of the head and neck: comparison of primary tumors, their neck metastases and normal tissue. Strahlenther Onkol 1998;174: 484-6.
4. Blitzer PH, Wang CC, Suit HD. Blood pressure and hemoglobin concentration: multivariate analysis of local control after irradiation for head and neck cancer. Int J Radiat Oncol Biol Phys:1984;10:Suppl 2:98.
5. Bryne M, Eide GE, Lilleng R, et al. A multivariate study of the prognostic of oral squamous cell carcinoma: are blood group and hemoglobin new prognostic factors? Cancer 1991;68:1994-8.
6. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986;12:2047-50.
7. Dische S. Radiotherapy and anemia-the clinical experience. Radiother Oncol 1991;20:35-40.
8. Dubray B, Mosseri V, Brunin F, et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996;201:553-8.
9. Duhrsen U, Hossfeld DK. Hematopoietic growth factors and the treatment of tumor-associated anemias. Ann Hematol 1994;69:213-21.
10. Dunphy FR, Dunleavy TL, Harrison BR, et al. Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin. Cancer 1997;79:1623-8.
11. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a metaanalysis of prospective and randomized trials. J Clin Oncol 1996;14: 838-47.
12. Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;8:2077-83.
13. Feldmann HJ, Molls M, Vaupel P. Blood flow and oxygenation status of human tumors. Clinical investigations. Strahlenther Onkol 1999;175:1-9.
14. FU KK. Combined radiotherapy for head and neck cancer (Meeting abstract). Int Congr Radiat Oncol, Kyoto, Japan. 1993:103.
15. Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and it's relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988;14:831-8.
16. Glaser C, Millesi W, Gössweiner S, et al. R-HuErythropoietin supply increases efficacy of neoadjuvant radio-chemotherapy in patients with oral squamous cell carcinoma. In: Proc Am Soc Clin Oncol. Los Angeles, 1998:Vol 17.
17. Graeber TG, Osmanian C, Jacks T. et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 1996; 379:88-91.
18. Grau C, Overgaard J. Significance of hemoglobin concentration for treatment outcome. In: Molls M, Vaupel P. eds. Blood perfusion and microenvironment of human tumors. Berlin-Heidelherg-New York: Springer, 1998:101-2.
19. Höckel M, Schlenger K, Mitze M, et al. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 1996;6:3-9.
20. Hughes RS, Frenkel EP. The role of chemotherapy in head and neck cancer. ASCO: Cancer Trials 1997;20:449-61.
21. Kelleher DK, Thews O, Vaupel P. Can erythropoietin improve tumor oxygenation? Strahlenther Onkol 1998;174:20-3.
22. Lavey DS, Dempsey WH. Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 1993;27: 1147-52.
23. Lavey RS. Clinical trial experience using erythropoietin during radiation therapy. Strahlenther Onkol 1998;174:24-30.
24. Mantovani G, Ghiani M, Lai P, et al. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study. Oncol Rep 1998;5: 1499-505.
25. Million R, Cassisi N, Clark J. Cancer of the head and neck. Principles and practice of oncology, 3rd edn. Philadelphia: Lippincott, 1989:488-98.
26. Mohr C, Bohndorf W, Carstens J, et al. Präoperative Radiochemotherapie und radikale Operation versus alleinige Radikaloperation fortgeschrittener Mundhöhlenkarzinome, 3-Jahres-Ergebnisse einer prospektiven, randomisierten Therapiestudie im Auftrag des DÖSAK. Dtsch Z Mund-Kiefer-Gesichts-Chir 1994;18:5-12.
27. Molls M, Stadler P, Becker A, et al. Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels. Strahlenther Onkol 1996;41:31-9.
28. Nordmarks M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
29. Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 1996;6:10-21.
30. Steiner W. Therapie des Hypopharynxkarzinoms. Teil II: Literaturübersicht zum Einsatz dor Chemotherapie im Rahmen multimodaler Therapiekonzepte. HNO 1994;42:84-8.
31. Tannock I, Cummings B, Sorrenti V. Combination chemotherapy used prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck. Cancer Treatm Rep 1982;66:1421-4.
32. Teicher B. Physiologic mechanisms of therapeutic resistance. Hemat Oncol Clin North Am 1995:9:475-507.
33. Thews O, Koenig R. Kelleher DK, et al. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anemia. Br J Cancer 1998;78:752-6.
34. van Acht MJJ, Hermans J, Boks DE, et al. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 1992;23:229-35.
35. Vaupel P. Thews O, Kelleher DK, et al. Oxygenation of human tumors: the Mainz experience. Strahlenther Onkol 1998;174:6-12.
36. Wagner W, Hartlapp J, Esser E, et al. Modified neoadjuvant therapy regime with low dose irradiation in advanced head and neck cancer patients: preliminary results of a pilot study to minimize side effects. Oncol Rep 1998;5:1251-3.
37. Wendt TG. Radiochemotherapie bei fortgeschrittenen Kopf-Hals-Tumoren - was ist gesichert? Strahlenther Oncol 1996;172:409-16.